Thrombocytopenia in pregnant patients with mild COVID-19
Since its emergence in December 2019, the outbreak of novel coronavirus disease 2019 (COVID-19) has infected over 2 626 321 people globally.1 COVID-19 is associated with wide variability in disease severity, ranging from asymptomatic to severe critical presentations. In initial data from China, mild thrombocytopenia was found to occur in just over a third of non-pregnant patients admitted to hospital with COVID-19. A more recent meta-analysis found that thrombocytopenia is associated with a three-fold greater risk of severe COVID-19.
Publication date: September 2020Source: American Heart Journal, Volume 227Author(s): Payam Dehghani, Laura J. Davidson, Cindy L. Grines, Keshav Nayak, Jacqueline Saw, Prashant Kaul, Akshay Bagai, Ross Garberich, Christian Schmidt, Hung Q. Ly, Jay Giri, Perwaiz Meraj, Binita Shah, Santiago Garcia, Scott Sharkey, David A. Wood, Frederick G. Welt, Ehtisham Mahmud, Timothy D. Henry